Neutral Jyothy Laboratories; target of Rs 190: Motilal Oswal

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

live

• bselive
• nselive

Volume

Todays L/H

More

×

Motilal Oswal's research report on Jyothy Laboratories

JYL reported an in line operating performance in 2QFY23. While standalone sales growth was 11.8%, overall volume growth was low ~1%. Three-year EBITDA CAGR continues to be in low single digits and is likely to remain at a similar rate over the next couple of quarters. We maintain our Neutral rating on the stock.

Outlook

We assign a 17x EV/EBITDA target multiple to our Sep’24E EBITDA, resulting in a TP of INR190. We maintain our Neutral rating.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Jyothy Laboratories - 15 -11-2022 - moti